shortage of tirzepatide Update: On December 19th the FDA ruled the tirzepatide was resolved, however is giving a grace period for compounding pharmacies to continuing manufacturing. This grace period is 60 days. On FDA: Shortage of Weight Loss

Engineering: This "No DAC" variant features four specific amino acid substitutions (Tetrasubstitution) that protect it from DPP-IV enzymatic cleavage, extending its biological activity to 30-60 minutesideal for mimicking natural physiological pulses

GLP-1 receptor agonists (short for glucagon-like peptide 1) are a class of medications that mimic a natural hormone in the body

Journal of Pineal Research, 72 (2), e12782

Additional Benefits: Burns more fat than standard GLP-1's

There is pigmentation spots I hope to erase

One of the most critical guidelines addresses the risk of microbial contamination in multi-dose vials